HNSE Asia AI Hardware Battle 2025 Adds Japan Retail Showcase for Top 10 Winners; Application Deadline Extended to July 12
This retail opportunity is powered by the Japan-based crowdfunding platform GREEN FUNDING, which is now a strategic partner of HNSE AHB, further strengthening the program's bridge between Asian hardware innovation and global consumer markets.
The new retail benefit extends HNSE AHB's original incentives, which already include round-trip airfare to the Grand Finale in Hainan on July 26, 2025, booth exhibition passes at the "Tech Meets Art" Festival, global media exposure, and investor matchmaking opportunities. HNSE AHB now gives founders direct access to Japan's influential tech-lifestyle audience. CCC Group operates more than 800 Tsutaya stores, widely regarded as design-forward cultural hubs that attract early adopters and trend watchers.
Products selected for the showcase must (1) confirm a campaign launch on the GREEN FUNDING platform, (2) clear GREEN FUNDING's internal screening process, and (3) meet CCC Group's scheduling criteria for store category fit and campaign timeline. Store locations and display periods will be determined at GREEN FUNDING's discretion, ensuring that each product is matched to the most suitable Tsutaya venue. Full terms and conditions are available from the HNSE AHB organizing team.
"By combining the creative reach of GREEN FUNDING with the cultural influence of Tsutaya Books, we are offering founders an end-to-end pathway from prototype to Japanese consumers in record time," said Dr. Gang Lu, Founder and Chief Executive Officer of the TechNode Group. "This is exactly the kind of market-entry catalyst our competition was designed to deliver."
Japan remains a leading global market for consumer technology, yet localization hurdles—ranging from language to retail distribution—can be a hurdle for overseas startups. GREEN FUNDING, founded in 2011 and owned by the CCC Group, is recognized as one of Japan's top crowdfunding portals for creative tech gadgets. Its promotion of hardware campaigns through both digital backer communities and physical Tsutaya stores has proven highly effective in driving early sales and media coverage.
Key dates: applications are extended to July 12, 2025, while on-site finals take place July 26, 2025 in Lingshui, Hainan, followed by the award ceremony on July 27, 2025. Eligible teams—startups and established firms alike—must present an AI-driven hardware product that has reached at least the prototype stage and fits one of HNSE AHB's focus sectors, including smart home, wearables, smart vehicles, robotics, and VR/AR.
With GREEN FUNDING now a strategic partner, HNSE AHB offers what we believe is an unparalleled launchpad: pitch in Hainan, secure investor backing, and debut in Japan's most celebrated lifestyle bookstores—all within the same summer. The countdown to the application deadline has begun; we look forward to welcoming the region's brightest hardware talents to the stage.
Interested innovators can apply via the registration link on the official event page at https://technode.global/hnse-ahb, scan the QR code in the poster, or contact elliesoo@technode.com for further guidance.
For any questions regarding this release, please contactContact Person: Ellie SooPhone Number: N/A Email: elliesoo@technode.com
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/hnse-asia-ai-hardware-battle-2025-adds-japan-retail-showcase-for-top-10-winners-application-deadline-extended-to-july-12-302497404.html
SOURCE TNGlobal
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
20 minutes ago
- Bloomberg
Japan's Real Wages Fall Most Since 2023 as Inflation Bites
Japanese workers' real wages dropped by the most since September 2023 as inflation continued to outpace salary growth, posing a growing problem for Prime Minister Shigeru Ishiba ahead of a key election taking place in about two weeks. Real wages declined 2.9% from a year earlier in May, compared to economists' consensus call of a 1.7% fall, the labor ministry reported Monday. Nominal wages rose 1% from the previous year, climbing at a much slower pace than economists expected.
Wall Street Journal
28 minutes ago
- Wall Street Journal
Gold Edges Lower on Possible Position Adjustments
2355 GMT — Gold edges lower in the early Asian session on possible position adjustments, but losses may be limited by concerns over U.S. policies. With this Wednesday's deadline for the 90-day pause on so-called reciprocal tariffs looming, President Trump said Sunday that a dozen or more letters could go out this week. Meanwhile, Trump signed his 'one big, beautiful bill' into law in a July 4th ceremony. A key factor supporting gold is the damaging U.S. policy, which is eroding investors' confidence in safe U.S. assets, says Commerzbank Research's head of FX and Commodity Research Thu Lan Nguyen in a note. Spot gold is 0.3% lower at $3,327.26/oz. (
Forbes
37 minutes ago
- Forbes
Another Look: Shanghai Henlius Shares Hit A Near Five-Year High
Investigators and global collaborators gathered at the Henlius reception during the annual meeting ... More of the American Society of Clinical Oncology held in Chicago May 30-June 3 this year. Last Tuesday I posted an interview by Forbes China with Jason Zhu, the CEO of Shanghai Henlius Biotech. Zhu said he sees more growth ahead for the drug maker based on a pipeline of cancer and ophthalmologic drugs, as well as expanded international partnerships. The company has had a good stretch since. Its Hong Kong-trade shares soared by almost 7% on Thursday from a day earlier to HK$55.95, their highest close in nearly five years. They eased back to HK$55.90 on Friday, but have risen 145% in the past year. This past week, the company announced EU GMP certification for the production lines of two drug candidates, accelerating their market entry prospects there; it also unveiled a new licensing partnership with HanchorBio. On June 27, Henlius's board approved a package of stock options and restricted stock units for Zhu and other key staff. Hong Kong-traded shares in Shanghai Fosun Pharmaceutical – which owns more than 60% of Shanghai Henlius – have trended upwards along with the Zhu-led company. They closed at HK$17.08 on Friday, compared with HK$15.92 on June 24.
